UK markets closed

MRNA Jan 2026 60.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.05000.0000 (0.00%)
As of 12:47PM EDT. Market open.
Full screen
Loading interactive chart…
  • Benzinga

    Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon

    On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of their combined melanoma treatment that consists of an experimental mRNA vaccine and Merck’s blockbuster immunotherapy, Keytruda. Pfizer Is Aiming To Set The Treatment Standard For Lung Cancer With encouraging results, Pfizer is getting another step closer t

  • Zacks

    FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains

    An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.

  • Zacks

    Company News for June 4, 2024

    Companies In The Article Are:NVDA, MRK,MRNA, SPOT, SRCL and WM